HEALTH (MSM)

Swiss biotech Actelion hits record high on potential Shire bid

Shares in Actelion , Europe’s biggest biotech company, jumped 10 percent to a record high on Monday after a report Shire was considering a $19 billion takeover of the Swiss group to boost its rare diseases business. Shire, which is based in Ireland but has most operations in the United States, is a serial acquirer in a consolidating healthcare sector, which has seen a record $253 billion of deals so